FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns a drug preparation showing cardioprotective, antiaggregant and anti-ischemic action on the cardiovascular system and containing acetylsalicylic acid, L-arginine hydrochloride and folic acid with L-arginine hydrochloride, acetylsalicylic acid and folic acid related as 300:50:1 respectively.
EFFECT: drug preparation shows high effectiveness with respect to said disorders.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARDIOPROTECTIVE AND ANTIARRHYTHMIC MEDICINE | 2022 |
|
RU2783444C1 |
| CARDIOPROTECTIVE, ANTIARRHYTHMIC ANTI-ISHEMIC AGENT | 2007 |
|
RU2366426C2 |
| HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
| MEDICINE FOR THE TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES | 2020 |
|
RU2790663C1 |
| IMPROVING THE RECOVERY FUNCTION OF THE CARDIOVASCULAR SYSTEM IN ISCHEMIA TETRADECAPEPTIDES | 2017 |
|
RU2648846C1 |
| N-(2,4,6-TRIMETHYLPHENYLCARBAMOYLMETHYL)-N-ALLYLMORPHOLINIUM BROMIDE SHOWING ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS AT ISCHEMIC HEART DISEASE AND A METHOD OF ITS SYNTHESIS | 1997 |
|
RU2105554C1 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
| METHOD FOR PREVENTING AND TREATING MYOCARDIAL ISCHEMIA | 2002 |
|
RU2241463C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND ACE INHIBITOR | 2016 |
|
RU2750934C2 |
